Actively Recruiting
Evaluating Human Gamma Globulin Treatment in Children With Severe Infection and Inflammatory Storms in Intensive Care
Led by Children's Hospital of Fudan University · Updated on 2026-03-16
200
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Critically ill children experiencing inflammatory storms may face severe immune damage, which can lead to multiple organ failure or death. This research aims to understand how human gamma globulin therapy might help control these inflammatory storms in severely infected children. The study is observational and seeks to provide reliable data to guide clinical use of gamma globulin in intensive care settings. The research compares children treated with human gamma globulin to those receiving conventional treatment in a pediatric intensive care unit. It retrospectively collects clinical and demographic data from electronic health records to evaluate the effectiveness and suitability of gamma globulin therapy. The study focuses on children hospitalized with severe infection complicated by inflammatory storms. Participants outcomes such as death rate within 28 days after discharge from the pediatric intensive care unit and length of stay in the unit will be measured. Additional immune and inflammatory markers including CD4CD8, C-reactive protein, and various interleukins will be assessed within 3 to 15 days after starting treatment. The study will help clinicians and pharmacists make informed decisions on gamma globulin use in this critically ill population.
CONDITIONS
Brief Title
Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm
Research Team
G
Guoping Lu, Doctor
Y
Yao Wang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here